Morningstar's Julie Stralow sees opportunities in both the debt and equity of medical device firms Stryker and Zimmer.
Andrew Salata of the Social Security Administration describes how the do-over, voluntary suspension, and pick-and-choose strategies can help retirees maximize their lifetime benefits.
Matrix Advisors Value manager David Katz explains the fund's new Zimmer, Genzyme, and Medtronic picks amid a still-uncertain health-care environment.
Core stock strategist Paul Larson highlights one recent pick in his StockInvestor Hare Portfolio, plus a super-wide-moat health-care firm for your watch list.
Good morning. I would like to turn the call over to Bob Marshall, Vice President, Investor Relations and Treasurer. Mr. Marshall, you may begin your call.
Mr. Blair, you may begin your call.
Mr. Blair, you may begin your conference.
Sir, you may begin.
©2012 Morningstar Advisor. All right reserved.